Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.

Serum troponin assays, widely used to detect acute cardiac ischemia, might be useful biomarkers to detect chronic cardiovascular disease (CVD). Cardiac-specific troponin-I (cTnI) and troponin-T (cTnT) generally detect myocardial necrosis equally well. In dialysis patients however, serum cTnT levels...

Full description

Bibliographic Details
Main Authors: Maurits S Buiten, Mihály K de Bie, Joris I Rotmans, Friedo W Dekker, Marjolijn van Buren, Ton J Rabelink, Christa M Cobbaert, Martin J Schalij, Arnoud van der Laarse, J Wouter Jukema
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4523186?pdf=render
id doaj-90e270afa0bf4b268b64551bfc8a73b8
record_format Article
spelling doaj-90e270afa0bf4b268b64551bfc8a73b82020-11-25T00:57:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01108e013424510.1371/journal.pone.0134245Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.Maurits S BuitenMihály K de BieJoris I RotmansFriedo W DekkerMarjolijn van BurenTon J RabelinkChrista M CobbaertMartin J SchalijArnoud van der LaarseJ Wouter JukemaSerum troponin assays, widely used to detect acute cardiac ischemia, might be useful biomarkers to detect chronic cardiovascular disease (CVD). Cardiac-specific troponin-I (cTnI) and troponin-T (cTnT) generally detect myocardial necrosis equally well. In dialysis patients however, serum cTnT levels are often elevated, unlike cTnI levels. The present study aims to elucidate the associations of cTnI and cTnT with CVD in clinically stable dialysis patients.Troponin levels were measured using 5th generation hs-cTnT assays (Roche) and STAT hs-cTnI assays (Abbott) in a cohort of dialysis patients. Serum troponin levels were divided into tertiles with the lowest tertile as a reference value. Serum troponins were associated with indicators of CVD such as left ventricular mass index (LVMI), left ventricular ejection fraction (LVEF) and the presence of coronary artery disease (CAD). Associations were explored using regression analysis.We included 154 consecutive patients, 68±7 years old, 77% male, 70% hemodialysis. Median serum cTnT was 51ng/L (exceeding the 99th percentile of the healthy population in 98%) and median serum cTnI was 13ng/L (elevated in 20%). A high cTnI (T3) was significantly associated with a higher LVMI (Beta 31.60; p=0.001) and LVEF (Beta -4.78; p=0.005) after adjusting for confounders whereas a high serum cTnT was not. CAD was significantly associated with a high cTnT (OR 4.70 p=0.02) but not with a high cTnI. Unlike cTnI, cTnT was associated with residual renal function (Beta:-0.09; p=0.006).In the present cohort, serum cTnI levels showed a stronger association with LVMI and LVEF than cTnT. However, cTnT was significantly associated with CAD and residual renal function, unlike cTnI. Therefore, cTnI seems to be superior to cTnT as a marker of left ventricular dysfunction in asymptomatic dialysis patients, while cTnT might be better suited to detect CAD in these patients.http://europepmc.org/articles/PMC4523186?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Maurits S Buiten
Mihály K de Bie
Joris I Rotmans
Friedo W Dekker
Marjolijn van Buren
Ton J Rabelink
Christa M Cobbaert
Martin J Schalij
Arnoud van der Laarse
J Wouter Jukema
spellingShingle Maurits S Buiten
Mihály K de Bie
Joris I Rotmans
Friedo W Dekker
Marjolijn van Buren
Ton J Rabelink
Christa M Cobbaert
Martin J Schalij
Arnoud van der Laarse
J Wouter Jukema
Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.
PLoS ONE
author_facet Maurits S Buiten
Mihály K de Bie
Joris I Rotmans
Friedo W Dekker
Marjolijn van Buren
Ton J Rabelink
Christa M Cobbaert
Martin J Schalij
Arnoud van der Laarse
J Wouter Jukema
author_sort Maurits S Buiten
title Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.
title_short Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.
title_full Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.
title_fullStr Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.
title_full_unstemmed Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.
title_sort serum cardiac troponin-i is superior to troponin-t as a marker for left ventricular dysfunction in clinically stable patients with end-stage renal disease.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Serum troponin assays, widely used to detect acute cardiac ischemia, might be useful biomarkers to detect chronic cardiovascular disease (CVD). Cardiac-specific troponin-I (cTnI) and troponin-T (cTnT) generally detect myocardial necrosis equally well. In dialysis patients however, serum cTnT levels are often elevated, unlike cTnI levels. The present study aims to elucidate the associations of cTnI and cTnT with CVD in clinically stable dialysis patients.Troponin levels were measured using 5th generation hs-cTnT assays (Roche) and STAT hs-cTnI assays (Abbott) in a cohort of dialysis patients. Serum troponin levels were divided into tertiles with the lowest tertile as a reference value. Serum troponins were associated with indicators of CVD such as left ventricular mass index (LVMI), left ventricular ejection fraction (LVEF) and the presence of coronary artery disease (CAD). Associations were explored using regression analysis.We included 154 consecutive patients, 68±7 years old, 77% male, 70% hemodialysis. Median serum cTnT was 51ng/L (exceeding the 99th percentile of the healthy population in 98%) and median serum cTnI was 13ng/L (elevated in 20%). A high cTnI (T3) was significantly associated with a higher LVMI (Beta 31.60; p=0.001) and LVEF (Beta -4.78; p=0.005) after adjusting for confounders whereas a high serum cTnT was not. CAD was significantly associated with a high cTnT (OR 4.70 p=0.02) but not with a high cTnI. Unlike cTnI, cTnT was associated with residual renal function (Beta:-0.09; p=0.006).In the present cohort, serum cTnI levels showed a stronger association with LVMI and LVEF than cTnT. However, cTnT was significantly associated with CAD and residual renal function, unlike cTnI. Therefore, cTnI seems to be superior to cTnT as a marker of left ventricular dysfunction in asymptomatic dialysis patients, while cTnT might be better suited to detect CAD in these patients.
url http://europepmc.org/articles/PMC4523186?pdf=render
work_keys_str_mv AT mauritssbuiten serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease
AT mihalykdebie serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease
AT jorisirotmans serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease
AT friedowdekker serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease
AT marjolijnvanburen serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease
AT tonjrabelink serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease
AT christamcobbaert serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease
AT martinjschalij serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease
AT arnoudvanderlaarse serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease
AT jwouterjukema serumcardiactroponiniissuperiortotroponintasamarkerforleftventriculardysfunctioninclinicallystablepatientswithendstagerenaldisease
_version_ 1725224788429897728